HUP9900659A2 - Alendronát alkalmazása oszteoporózis megelőzésére - Google Patents
Alendronát alkalmazása oszteoporózis megelőzéséreInfo
- Publication number
- HUP9900659A2 HUP9900659A2 HU9900659A HUP9900659A HUP9900659A2 HU P9900659 A2 HUP9900659 A2 HU P9900659A2 HU 9900659 A HU9900659 A HU 9900659A HU P9900659 A HUP9900659 A HU P9900659A HU P9900659 A2 HUP9900659 A2 HU P9900659A2
- Authority
- HU
- Hungary
- Prior art keywords
- alendronate
- prevention
- osteoporosis
- hydroxybutylidene
- bisphosphonate
- Prior art date
Links
- OGSPWJRAVKPPFI-UHFFFAOYSA-N Alendronic Acid Chemical compound NCCCC(O)(P(O)(O)=O)P(O)(O)=O OGSPWJRAVKPPFI-UHFFFAOYSA-N 0.000 title abstract 3
- 229940062527 alendronate Drugs 0.000 title abstract 2
- 230000002265 prevention Effects 0.000 title abstract 2
- 208000001132 Osteoporosis Diseases 0.000 title 1
- 239000003814 drug Substances 0.000 abstract 1
- 208000001685 postmenopausal osteoporosis Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Physical Education & Sports Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Rheumatology (AREA)
- Epidemiology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Diabetes (AREA)
- Nutrition Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
A találmány tárgya alendronát, azaz 4-amino-1-hidroxi-butilidén-1,1-biszfoszfonát alkalmazása a nők korai posztmenopauzálisoszteoporózisának megelőzését szolgáló gyógyszer előállítására. Ó
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US45819595A | 1995-06-02 | 1995-06-02 | |
PCT/US1996/007912 WO1996038156A1 (en) | 1995-06-02 | 1996-05-29 | Use of alendronate for the prevention of osteoporosis |
Publications (2)
Publication Number | Publication Date |
---|---|
HUP9900659A2 true HUP9900659A2 (hu) | 2001-04-28 |
HUP9900659A3 HUP9900659A3 (en) | 2002-12-28 |
Family
ID=23819759
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU9900659A HUP9900659A3 (en) | 1995-06-02 | 1996-05-29 | Use of alendronate for prevention of osteoporosis |
Country Status (21)
Country | Link |
---|---|
EP (1) | EP0828496A1 (hu) |
JP (1) | JPH10506648A (hu) |
KR (1) | KR19990022436A (hu) |
CN (1) | CN1192685A (hu) |
AU (1) | AU709196B2 (hu) |
BG (1) | BG63103B1 (hu) |
BR (1) | BR9609020A (hu) |
CA (1) | CA2222318A1 (hu) |
CZ (1) | CZ381197A3 (hu) |
EA (1) | EA000677B1 (hu) |
EE (1) | EE03306B1 (hu) |
HU (1) | HUP9900659A3 (hu) |
IL (1) | IL118422A0 (hu) |
IS (1) | IS4617A (hu) |
NO (1) | NO975527L (hu) |
NZ (1) | NZ308935A (hu) |
PL (1) | PL323669A1 (hu) |
SK (1) | SK159597A3 (hu) |
TR (1) | TR199701482T1 (hu) |
WO (1) | WO1996038156A1 (hu) |
ZA (1) | ZA964465B (hu) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20010031244A1 (en) | 1997-06-13 | 2001-10-18 | Chiesi Farmaceutici S.P.A. | Pharmaceutical aerosol composition |
SE9901272D0 (sv) * | 1999-04-09 | 1999-04-09 | Astra Ab | New improved formulation |
KR100317935B1 (ko) * | 1999-10-20 | 2001-12-22 | 유승필 | 대사성 골질환 치료용 약제조성물 및 이의 제조방법 |
BR0209360A (pt) * | 2001-05-02 | 2004-06-08 | Novartis Ag | Método de administração de bisfosfonatos por inalação no tratamento ou prevenção de reabsorção óssea e osteoporose |
JP2010043119A (ja) * | 2009-10-16 | 2010-02-25 | Gador Sa | 骨の代謝病の予防および/または治療のための組成物、その組成物の調製方法およびその使用 |
KR102472749B1 (ko) * | 2022-01-18 | 2022-12-02 | 주식회사 위엔씨 | 유해가스제거 및 항균탈취기능을 함유한 흡착소재 제조방법 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5366965A (en) * | 1993-01-29 | 1994-11-22 | Boehringer Mannheim Gmbh | Regimen for treatment or prophylaxis of osteoporosis |
US5462932A (en) * | 1994-05-17 | 1995-10-31 | Merck & Co., Inc. | Oral liquid alendronate formulations |
-
1996
- 1996-05-27 IL IL11842296A patent/IL118422A0/xx unknown
- 1996-05-29 CZ CZ973811A patent/CZ381197A3/cs unknown
- 1996-05-29 EA EA199700449A patent/EA000677B1/ru not_active IP Right Cessation
- 1996-05-29 BR BR9609020A patent/BR9609020A/pt not_active Application Discontinuation
- 1996-05-29 EP EP96920553A patent/EP0828496A1/en not_active Withdrawn
- 1996-05-29 AU AU58824/96A patent/AU709196B2/en not_active Ceased
- 1996-05-29 JP JP8536616A patent/JPH10506648A/ja active Pending
- 1996-05-29 SK SK1595-97A patent/SK159597A3/sk unknown
- 1996-05-29 KR KR1019970708917A patent/KR19990022436A/ko not_active Application Discontinuation
- 1996-05-29 TR TR97/01482T patent/TR199701482T1/xx unknown
- 1996-05-29 PL PL96323669A patent/PL323669A1/xx unknown
- 1996-05-29 NZ NZ308935A patent/NZ308935A/en unknown
- 1996-05-29 CN CN96196075A patent/CN1192685A/zh active Pending
- 1996-05-29 CA CA002222318A patent/CA2222318A1/en not_active Abandoned
- 1996-05-29 HU HU9900659A patent/HUP9900659A3/hu unknown
- 1996-05-29 WO PCT/US1996/007912 patent/WO1996038156A1/en not_active Application Discontinuation
- 1996-05-29 EE EE9700308A patent/EE03306B1/xx not_active IP Right Cessation
- 1996-05-31 ZA ZA964465A patent/ZA964465B/xx unknown
-
1997
- 1997-11-19 IS IS4617A patent/IS4617A/is unknown
- 1997-11-20 BG BG102060A patent/BG63103B1/bg unknown
- 1997-12-01 NO NO975527A patent/NO975527L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
PL323669A1 (en) | 1998-04-14 |
IS4617A (is) | 1997-11-19 |
BG63103B1 (bg) | 2001-04-30 |
EA199700449A1 (ru) | 1998-06-25 |
JPH10506648A (ja) | 1998-06-30 |
CN1192685A (zh) | 1998-09-09 |
BG102060A (en) | 1998-07-31 |
AU709196B2 (en) | 1999-08-26 |
CZ381197A3 (cs) | 1998-06-17 |
WO1996038156A1 (en) | 1996-12-05 |
SK159597A3 (en) | 1998-06-03 |
NO975527D0 (no) | 1997-12-01 |
TR199701482T1 (xx) | 1998-03-21 |
CA2222318A1 (en) | 1996-12-05 |
HUP9900659A3 (en) | 2002-12-28 |
EP0828496A1 (en) | 1998-03-18 |
IL118422A0 (en) | 1996-09-12 |
BR9609020A (pt) | 1999-07-06 |
ZA964465B (en) | 1996-12-11 |
EA000677B1 (ru) | 2000-02-28 |
NZ308935A (en) | 2000-07-28 |
EE03306B1 (et) | 2000-12-15 |
AU5882496A (en) | 1996-12-18 |
KR19990022436A (ko) | 1999-03-25 |
NO975527L (no) | 1997-12-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX9800401A (es) | Sistema transcorneal de liberacion de medicamentos. | |
NO20000935D0 (no) | Fremgangsmåte for inhibering av komplementaktivering via den alternative reaksjonsvei | |
BG101901A (en) | 2-methyl-thieno-benzodiazepine formulation for oral application | |
DK0859889T3 (da) | Slidenhed til gravekanten på en graveindretning | |
FI960851A0 (fi) | Menetelmä N-amino-1-hydroksi-alkylideeni-1,1-bisfosfonihappojen valmistamiseksi | |
DK0756484T3 (da) | Vådgranuleringsformulering til diphosphonsyrer | |
HUP9900659A2 (hu) | Alendronát alkalmazása oszteoporózis megelőzésére | |
CA2024694A1 (en) | Acyloxymethyl esters of bisphosphonic acids as bone resorption inhibitors | |
AU1160700A (en) | Ppar gamma ligands | |
BG103649A (en) | Method for the preparation of eprosartan | |
AU6148396A (en) | Disodium alendronate formulations | |
BG103650A (en) | Method for the preparation of eprosartan | |
ZA200110450B (en) | Oral preparations of etidronate disodium. | |
FR2710518B1 (fr) | Ensemble de mise en place d'une prothèse formée d'un tissu souple. | |
MX9706277A (es) | El uso del alendronato para preparar composiciones para reducir el riesgo de fracturas oseas no vertebrales. | |
PT832883E (pt) | Compostos de tetrahidrobenzo(a)fluoreno e metodos de uso | |
KR970046824U (ko) | 웨이퍼 플랫존 정렬장치 | |
GR1002390B (el) | Συστημα καλουπωματος δια ενα τοιχο με μανδυα απο μπετον. | |
IT240826Y1 (it) | Calzatura per la pratica di uno sport per slittamento | |
FR2704129B1 (fr) | Urinal individuel pour homme. | |
BR7502638U (pt) | Tênis computadorizado | |
IT1278184B1 (it) | Metodo per la realizzazione di suole per calzature | |
IT1281441B1 (it) | Procedimento per la fabbricazione di scarpe | |
ITTO930166A0 (it) | Procedimento per il trattamento di flussi reflui della produzione di n-fosfonometilglicina. | |
MX9604751A (es) | Plantilla. |